Pfizer Inc (PFE)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 63,627,000 | 58,496,000 | 100,330,000 | 81,288,000 | 41,908,000 |
| Property, plant and equipment | US$ in thousands | — | 18,940,000 | 16,274,000 | 14,882,000 | 13,900,000 |
| Fixed asset turnover | — | 3.09 | 6.17 | 5.46 | 3.01 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $63,627,000K ÷ $—K
= —
The fixed asset turnover ratio reflects Pfizer Inc's efficiency in utilizing its fixed assets to generate revenue.
From December 31, 2020, to December 31, 2021, Pfizer significantly improved its fixed asset turnover from 3.01 to 5.46, indicating that the company generated $5.46 in revenue for every $1 of fixed assets invested, highlighting increased efficiency in asset utilization.
This trend continued into December 31, 2022, showing a further improvement in fixed asset turnover to 6.17. This signifies that Pfizer continued to effectively leverage its fixed assets to generate revenue.
However, by December 31, 2023, the fixed asset turnover ratio dropped to 3.09. This could suggest a potential decrease in efficiency in utilizing fixed assets to generate revenue compared to the previous year.
Unfortunately, the data for December 31, 2024, is not available (denoted by '—'), making it challenging to provide further analysis for that period.
Overall, Pfizer Inc's fixed asset turnover ratio has shown both positive and negative fluctuations over the years, indicating varying levels of efficiency in utilizing fixed assets to generate revenue. Further analysis and contextual information would be needed to better understand the reasons behind these fluctuations.
Peer comparison
Dec 31, 2024